Israel’s IMC looks to spin out, sell cannabis unit in pivot to biotech sector
IM Cannabis Corp. is proposing a reverse merger with Israeli biotechnology firm Kadimastem in which it would spin out – and potentially sell – its existing medical marijuana operations in Israel and Germany.